Structure, binding and neutralization of VHSV with synthetic peptides

Virus Research

Volumn 63, Issue 1-2, 1999, Pages 27-34

  Estepa, A ^a   Fernandez Alonso, M ^b   Coll, J M ^b  

^a MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^b Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria   (Spain)

Author keywords

Inhibitory peptides; Salmonid rhabdovirus; Viral peptides

Indexed keywords

COMPLEMENTARY DNA; PEPTIDE; PHOSPHATIDYLSERINE; PHOSPHOLIPID; THROMBOSPONDIN; VIRUS GLYCOPROTEIN;

BINDING SITE; COMPUTER MODEL; CONFERENCE PAPER; CONTROLLED STUDY; FISH; MEMBRANE FUSION; MOLECULAR CLONING; MOLECULAR MODEL; NONHUMAN; PEPTIDE SYNTHESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RHABDOVIRUS; VIRAL HEMORRHAGIC SEPTICEMIA VIRUS; VIRUS INFECTIVITY; VIRUS NEUTRALIZATION;

ANIMALS; BIOTINYLATION; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; MODELS, MOLECULAR; PEPTIDE FRAGMENTS; PROTEIN BINDING; RHABDOVIRIDAE; VIRAL ENVELOPE PROTEINS; VIRAL FUSION PROTEINS;

RHABDOVIRIDAE; SALMONIDAE; VIRAL HEMORRHAGIC SEPTICEMIA VIRUS;

EID: 0032855228     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(99)00055-6     Document Type: Conference Paper

References (33)

1. Bearzotti M., Monnier A.F., Vende P., Grosclaude J., de Kinkelin P., Benmansour A. The glycoprotein of viral hemorrhagic septicemia virus (VHSV): antigenicity and role in virulence. Vet. Res. Comm. 26:1995;413-422.
2. Benmansour A., Basurco B., Monnier A.F., Vende P., Winton J.R., de Kinkelin P. Sequence variation of the glycoprotein gene identifies three distinct lineages within field isolates of viral haemorrhagic septicemia virus, a fish rhabdovirus. J. Gen. Virol. 78:1997;2837-2846.
3. Chan D.C., Fass D., Berger J.M., Kim P.S. Core structure of gp41 from the HIV envelope glycoprotein. Cell. 89:1997;263-273.
4. Chen T.T., Lu J.K., Shamblott M.J., Cheng C.M., Lin C.M., Burns J.C., Reimschuessel R., Chatakondi N., Dunham R.A. Transgenic fish: ideal models for basic research and biotechnological applications. Zool. Stud. 34:1995;215-234.
5. Coll J.M. The glycoprotein G of rhabdoviruses. Arch. Virol. 140:1995;827-851.
6. Coll J.M. Heptad-repeat sequences in the glycoprotein of rhabdoviruses. Virus Genes. 10:1995;107-114.
7. Coll J.M. Low-pH increases the binding of haemorrhagic septicemia rhabdovirus to membrane phospholipids. J. Fish Dis. 18:1996;519-527.
8. Coll J.M. Synthetic peptides from the heptad repeats of the glycoproteins of rabies, vesicular stomatitis and fish rhabdoviruses bind phosphatidylserine. Arch. Virol. 142:1997;2089-2097.
9. Epand R.M., Cheetam J.J., Epand R.F., Yeagle P.L., Richardson C.D., Rockwell A., DeGrado W.F. Peptide models for the membrane destabilizing actions of viral fusion proteins. Biopolymers. 32:1992;309-314.
10. Estepa A., Coll J.M. Pepscan mapping and fusion related properties of the major phosphatidylserine-binding domain of the glycoprotein of viral hemorrhagic septicemia virus, a salmonid rhabdovirus. Virology. 216:1996;60-70.
11. Estepa A., Coll J.M. Phosphatidylserine binding to solid-phase peptides: a new method to study phospholipid/viral protein interactions. J. Virol. Method. 61:1996;37-45.
12. Estepa A., Coll J.M. Temperature and pH requirements for viral haemorrhagic septicemia virus induced cell fusion. Dis. Aquat. Org. 28:1997;185-189.
13. Gaudin Y., Ruigrok R.W.H., Knossow M., Flamand A. Low-pH conformational changes of rabies virus glycoprotein and their role in membrane fusion. J. Virol. 67:1993;1365-1372.
14. Gaudin Y., Tuffereau C., Durrer P., Flamand A., Ruigrok R.W.H. Biological function of the low-pH, fusion-inactive conformation of rabies virus glycoprotein (G): G is transported in a fusion-inactive state-like conformation. J. Virol. 69:1995;5528-5534.
15. Lambert D.M., Barney S., Lambert A.L., Guthrie K., Medinas R., Davis D.E., Bucy T., Erickson J., Merutka G., Petteway S.R. Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. Proc. Natl. Acad. Sci. USA. 93:1996;2186-2191.
16. Lecocq-Xhonneux F., Thiry M., Dheur I., Rossius M., Vanderheijden N., Martial J., de Kinkelin P. A recombinant viral haemorrhagic septicaemia virus glycoprotein expressed in insect cells induces protective immunity in rainbow trout. J. Gen. Virol. 75:1994;1579-1587.
17. Lorenzen N., Olesen N.J., Jørgensen P.E.V., Etzerodt M., Holtet T.L., Thorgersen M.C. Molecular cloning and expression in Escherichia coli of the glycoprotein gene of VHS virus and immunization of rainbow trout with the recombinant protein. J. Gen. Virol. 74:1993;623-630.
18. Lorenzo G., Estepa A., Coll J.M. Fast neutralization/immunoperoxidase assay for viral haemorrhagic septicemia with anti-nucleoprotein monoclonal antibody. J. Virol. Method. 58:1996;1-6.
19. Lupas A., Van Dyke M., Stock J. Predicting coiled coils from protein sequences. Science. 252:1991;1162-1169.
20. Nieva J.L., Nir S., Muga A., Goñi F.M., Wilschut J. Interaction of the HIV-1 fusion peptide with phospholipid vesicles: different structural requirements for fusion and leakage. Biochemistry. 33:1994;3201-3209.
21. Nuñez E., Fernandez A.M., Estepa A., Gonzalez-Ros J.M., Gavilanes F., Coll J.M. Phospholipid interactions of a peptide from the heptad-repeats of the glycoprotein of VHSV, a fish rhabdovirus. Virology. 243:1998;322-330.
22. Owens R.J., Tanner C.C., Mulligan M.J., Srinivas R.V., Compas R.W. Oligopeptide inhibitors of HIV-induced syncytium formation. AIDS Res. Hum. Retrovir. 6:1990;1289-1296.
23. Rapaport D., Ovadia M., Shai Y. A synthetic peptide corresponding to a conserved heptad repeat domain in a potent inhibitor of Sendai virus-cell fusion: an emerging similarity with functional domains of other viruses. EMBO J. 14:1995;5524-5531.
24. Schlegel R., Willigan M.C., Pastan I.H. Saturable binding sites for vesicular stomatitis virus on the surface of vero cells. J. Virol. 43:1982;871-875t.
25. Schnell M.J., Buonocore L., Boritz E., Ghosh H.P., Chernish R., Rose J.K. Requirement for a non-specific glycoprotein cytoplasmic domain sequence to drive efficient budding of vesicular stomatitis virus. EMBO J. 17:1998;1289-1296.
26. Shokralla S., He Y., Wanas E., Ghosh H.P. Mutations in a carboxy-terminal region of vesicular stomatitis virus glycoprotein G that affect membrane fusion activity. Virology. 242:1998;39-50.
27. Thiry M., Lecoq-Xhonneux F., Dheur I., Renard A., de. Kinkelin P. Molecular cloning of the mRNA coding for the G protein of the viral haemorrhagic septicaemia (VHS) of salmonids. J. Vet. Microbiol. 23:1991;221-226.
28. Thiry M., Lecoq-Xhonneux F., Dheur I., Renard A., de Kinkelin P. Sequence of a cDNA carrying the glycoprotein gene and part of the matrix protein M2 gene of viral haemorrhagic septicaemia virus, a fish rhabdovirus. Biochim. Biophys. Acta. 1090:1991;345-347.
29. Wild C., Greenwell T., Matthews T. A synthetic peptide from HIV-1 gp41 is a potent inhibitor of virus-mediated cell-cell fusion. AIDS Res. Hum. Retrovir. 9:1993;1051-1053.
30. Wild C., Greenwell T., Shugars D., Rimsky-Clarke L., Matthews T. The inhibitory activity of an HIV type 1 peptide correlates with its ability to interact with a leucine zipper structure. AIDS Res. Hum. Retrovir. 11:1995;323-325.
31. Wild C., McDanal C., Bolognesi D., Mathews T. A synthetic peptide inhibitor of human immunodeficincy virus replication: correlation between solution structure and viral inhibition. Proc. Natl. Acad. Sci. USA. 77:1992;3273-3277.
32. Wild T.F., Buckland R. Inhibition of measles virus infection and fusion with peptides corresponding to the leucine zipper region of the fusion protein. J. Gen. Virol. 78:1997;107-111.
33. Yao Q., Compans R.W. Peptides corresponding to the heptad repeat sequence of human parainfluenza virus fusion protein are potent inhibitors of virus infection. Virology. 223:1996;103-112.